Prof. Kathy Pritchard-Jones, President

Kathy Pritchard-Jones is President of SIOP and Professor of Paediatric Oncology at University College London (UCL) Great Ormond Street Institute of Child Health. She is one of the UK’s foremost experts in childhood kidney cancers, where she has extensive experience of running multi-centre and international clinical trials and translational research. She has a track record of enabling partnership working to deliver quality improvement in complex care and to accelerate research. Throughout her career she has been an active member of the work of the national Children’s Cancer and Leukaemia Group (CCLG), the International Society of Paediatric Oncology (SIOP) and SIOP Europe.  She has run national and international clinical trials and a translational research laboratory focussed on kidney cancers. She has published over 200 articles in the field of childhood cancer.

Dr. Gregory Reaman, Treasurer

Gregory H. Reaman, M.D. is Professor of Pediatrics at George Washington University School of Medicine and Health Sciences in Washington, D.C. and a member of the Division of Hematology-Oncology and Executive Director Emeritus of the Center for Cancer and Blood Disorders at the Children’s National Medical Center, which he directed for more than 17 years. He is the Inaugural Chair of the Children’s Oncology Group (COG) having served in this capacity from 2000 through 2010. The COG is comprised of over 200 member institutions, dedicated to clinical, translational, and epidemiology research in childhood cancer. Prior to this, he was the Vice Chair for Scientific Affairs and the Associate Chair for New Agent Studies of the Children’s Cancer Group (CCG) for 10 years and directed the CCG Phase I Consortium. He joined the FDA in 2011 as the Associate Director for Oncology Sciences in the Office of Hematology and Oncology in the Center for Drug Evaluation and Research. Dr. Reaman serves or has served on several editorial boards: he served as an Associate Editor of Cancer and Leukemia and Lymphoma. He served on the Board of Directors of the American Cancer Society and chaired its Task Force on Children and Cancer and has served on the Board of Directors of the American Society of Clinical Oncology (ASCO) and has served on numerous ASCO committees. He was elected to the Board of SIOP as treasurer in 2011. His research interests are in the biology and treatment of childhood acute leukemia and new drug development for pediatric cancers. He is the author of more than 350 peer – reviewed manuscripts and 20 book chapters and 3 text books.

Prof. Eric Bouffet, Advocacy Chair and former SIOP President

Dr. Eric Bouffet is a Professor of Paediatrics at the University of Toronto; Garron Family Chair in Childhood Cancer Research; and Head of the Neuro-Oncology Section in the Division of Haematology/Oncology at The Hospital for Sick Children in Toronto, Canada. He is a Senior Associate Scientist in the Research Institute at the Hospital for Sick Children. He was the Former President for the International Society of Paediatric Oncology (SIOP) with a term from 2016-2019, and is now the Advocacy Chair for SIOP. From 1998-2001 he was co-Chairman of the Brain Tumour Committee of SIOP, and he is Chair of the Canadian Paediatric Brain Tumour Consortium since 2003. Dr. Bouffet is a member of the steering committee of the Brain Tumour Committee of the Children’s Oncology Group (COG).

Dr. Scott Howard, Secretary-General

After training in internal medicine, pediatrics, and epidemiology at the University of Tennessee and completing a hematology/oncology fellowship at St. Jude Children’s Research Hospital, Dr. Howard worked there for 16 years treating children with leukemia and lymphoma and conducting research in oncology supportive care and international oncology. He is particularly interested in management of patients with leukemia and lymphoma and all aspects of oncology supportive care (e.g. infectious complications, tumor lysis syndrome, thrombosis, venous access complications, endocrine and bone toxicities), and has experience facilitating local, national, and regional clinical research in a number of middle-income countries. In 2015, he founded Resonance Oncology to improve care for cancer patients everywhere, but especially in low- and middle-income countries (LMIC), through research, healthcare information technology, education, and development of regional and global networks for care and research. To complement these efforts, Scott conducts translational research at the University of Memphis (Memphis, Tennessee, USA) using large animal models of chemotherapy toxicity. Dr. Howard has a long history of working with SIOP colleagues to address issues in LMIC and to foster education and network building.  He currently chairs the Clinical Practice Guidelines Committee of the American Society of Pediatric Hematology Oncology and the SIOP PODC Twinning Working Group, whose goal is to promote local, regional, and global collaboration.

Dr. Khan Muhammad Saghir, Co-Chair of Pediatric Oncology Developing Countries (PODC)

Dr. Sandra Luna-Fineman, Co-Chair of Pediatric Oncology Developing Countries (PODC)

Dr. Lindsay Frazier, Continental President North America

Prof. Pamela Kearns, Continental President Europe

Prof. Pam Kearns is Chair of Clinical Paediatric Oncology at the University of Birmingham, where is Director of the Institute of Cancer and Genomic Sciences and Director of the Cancer Research UK Clinical Trials Unit (CRCTU). She is also an Honorary Consultant Paediatric Oncologist at Birmingham Women and Children’s Hospital. As Director of CRCTU, she leads the research strategy for UK’s largest cancer trials unit, delivering a trials portfolio of over 120 multi-centre & international cancer trials for a wide-range of cancers, occurring in all children, young people and adults across 347 centres in 21 countries. Notably, she leads the Cancer Research UK funded National Children’s Cancer Trials Teams. In 2015, she was appointed as a Senior Clinical Advisor to Cancer Research UK. In January 2019, Professor Kearns became President of the European Society of Paediatric Oncology (SIOP Europe). She also sits on the Boards for both the European consortium for Innovative Therapeutics for Children with Cancer (ITCC); a consortium developing early phase clinical trials for childhood cancers through International partnerships and ACCELERATE; a multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancer.  Through her leading roles within the University of Birmingham, Cancer Research UK and SIOP-Europe, she provides national and international expert advice and guidance on research governance, regulatory affairs and research ethics in relation to clinical trials. She leads the ITCC’s European consortium of academic trial sponsors from 7 countries developing and delivering a platform for efficient and accelerated delivery of academic early phase childhood cancer trials in UK & across Europe.

Arturo Moreno, Continental President Latin America

Leila Hessissen, Continental President Africa

Laila Hessissen is a Professor of Pediatrics in the Medical School of Rabat, Morocco, where she has been a faculty member since 2000. She also works as a Pediatric Hematology Oncologist at the Pediatric Hematology Oncology Centre of Rabat. Laila received her Pediatric Oncology University Diploma from the Paris-Sud University in France in 2000. Laila is the former President of the Moroccan Society of Pediatric Oncology Hematology, Vice General Secretary of the French-African Group of Pediatric Oncology (GFAOP), and she is the Continental President of SIOP-Africa. Since 2014, Laila has been involved in the creation and supervision of a Certified Diploma of Pediatric Oncology for clinicians in French-Speaking African Countries. This program takes place at the Mohammed 5 University of Rabat and is recognized by the Paris-Sud University in France. Through this program, she has developed the e-GFAOP e-learning platform for participants in the diploma program as well as a network of practical training sites. She is interested in pediatric brain tumors, genetic predisposition, and metronomic chemotherapy.

Rashmi Dalvi, Continental President Asia

Prof. Michael Sullivan, Continental President Oceania

Donna Johnson, Local Organizing Committee Chair

Prof. Dr. Stephen Hunger, Treasurer Elect

Dr. Hunger is Professor of Pediatrics, the Jeffrey E. Perelman Distinguished Chair in the Department of Pediatrics, Chief of the Division of Pediatric Oncology and Director of the Center for Childhood Cancer Research at the Children’s Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania. Dr. Hunger is Professor of Pediatrics, the Jeffrey E. Perelman Distinguished Chair in the Department of Pediatrics, Chief of the Division of Pediatric Oncology and Director of the Center for Childhood Cancer Research at the Children’s Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania. Dr. Hunger is an internationally recognized expert in the molecular genetics and treatment of childhood ALL and was Chair of the Children’s Oncology Group ALL Disease Committee from 2008-15 and leads the COG ALL TARGET project, which has led to major new insights into the genetics of ALL and identified important new therapeutic targets. Dr. Hunger also has an interest in global health with a focus on improving treatment for children with ALL in low and middle income countries.

Incoming Members of the Board of Directors (as of October 2020):

Dr. Julia Challinor, Secretary-General Elect

Julia Challinor, (RN, PhD, MS in Education and MS in Med Anthropology) serves as a consultant for multiple international projects for childhood cancer and pediatric oncology nursing, including the APHON Spanish Chemotherapy/Biotherapy course in Latin America. She was the Educational Liaison for children with cancer and those who had survived their disease at the University of California, San Francisco from 1993-2003. During 1994-2006, she also headed A Tomorrow for Children Foundation and worked in partnership with pediatric oncology centers that are members of the Asociación de Hemato-Oncología Pediátrica de Centro America (AHOPCA), collaborating with Jude Children’s Research Hospital, the Pediatric Oncology Group of Ontario (Canada) (POGO), and the Monza International School of Pediatric Hematology/Oncology (Italy) (MISPHO). Recently she has participated in pediatric oncology nursing initiatives in Ethiopia and India. As the International Society of Paediatric Oncology (SIOP) Advocacy Officer Julia has participated in the WHO Global Childhood Initiative for Childhood Cancer (GICC) since 2018, the WHO (GICC) workshop in Lima Peru in 2019 and ongoing related nursing projects in the country. Other tasks include a continued role in WHO GICC nursing issues and the SIOP Global Mapping of Pediatric Oncology Services project.

Lisa Morrissey, Chair of the Nursing Committee

Lisa is a nurse leader in the Dana-Farber/Boston Children’s Hospital (DF/BCH) Cancer and Blood Disorders Program in Boston, MA. She holds an MSN degree in Nursing Administration from Northeastern University, and a MPH in Healthcare Management from Harvard School of Public Health. Lisa is the Nurse Manager for the Inpatient Hematology/Oncology/Research at BCH, and Director of the BHC Global Nurse Fellowship program. She has led several nursing global partnerships in resource-limited countries including Tanzania, Central America, the Dominican Republic and Myanmar, promoting education, professionalism and collaboration for pediatric oncology nurses. Lisa is co-chair of the SIOP PODC Nursing workgroup and an active member of the SIOP Nursing Baseline Standards Task Force.

Dr. Joyce Kambugu, Continental President Elect-Africa

Dr. Hiroki Hori, Continental President Elect-Asia